TG Therapeutics
Price & Volume
Stats
See more52W Range | $25.28-$44.65 |
Market Cap | $5.8B |
Shares Short | 28M |
Financials
See moreRevenue (12 Mos) | $700.3M |
Revenue Growth (YoY) | 69.6% |
Gross Profit (12 Mos) | $581.6M |
Diluted EPS | $2.86 |
News
See moreYahoo Finance • 12 hours ago
Vericel Revenue Jumped 20%. One Biotech Investor Just Reported Adding $63 Million More
Yahoo Finance • 5 days ago
TG Therapeutics Announces Data Presentations for BRIUMVI® at the 2026 Consortium of Multiple Sclerosis Centers Annual Meeting
Yahoo Finance • 24 days ago
Dow Jones Futures: Stock Market Hits Highs On Iran-Deal Hopes; Nvidia Leads New Buys; ARM Flexes On Earnings
Yahoo Finance • 3 months ago
BRIUMVI Momentum Leads to Strong Execution for TG Therapeutics (TGTX)
About
CEO | Mr. Michael S. Weiss Esq., J.D. |
CFO | Mr. Sean A. Power CPA |
Address | 3020 Carrington Mill Blvd., Morrisville, NC, United States, 27560 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 399 |